Search results
Democrats ramp up patent fight with drug industry in bid to lower prices
Washington Post· 8 hours agoDemocrats have hit on a new tactic in their long battle with drug companies: challenge patents that...
Cost and Dilantin: Financial assistance options, savings, more
Medical News Today· 23 hours agoDilantin (phenytoin sodium) is a brand-name drug prescribed to treat or prevent certain types of...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters via Yahoo News· 14 hours agoAbbVie’s top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine...
Eli Lilly Is Trading At A Record High Ahead Of A Key FDA Meeting — Is It A Buy?
Investor's Business Daily· 6 hours agoThe company also calls for adjusted earnings of $13.50 to $14 a share. Both measures topped...
Bipartisan Efforts To Legislate Pharmaceutical Patent Reform Heat Up
Forbes· 5 days agoToday, multiple bipartisan bills have been introduced that seek to rein in different ways that drug...
Rx drug shortages hit all-time high, affecting prices
WTTV via Yahoo News· 3 days agoINDIANAPOLIS – Across the nation, consumers are dealing with the effects of prescription drug...